Personalized CHF treatment: PCT to guide therapy in heart failure patients

International Journal of Cardiology

Volumn 176, Issue 2, 2014, Pages 307-308

  Lee, Noel S ^a   Daniels, Lori B ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarkers; Dyspnea; Heart failure; Pneumonia; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ACUTE HEART FAILURE; ANTIBIOTIC THERAPY; DYSPNEA; HEART FAILURE; HORMONE BLOOD LEVEL; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MORTALITY; PERSONALIZED MEDICINE; PNEUMONIA; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; PROCEDURES;

BIOLOGICAL MARKERS; CALCITONIN; HEART FAILURE; HUMANS; INDIVIDUALIZED MEDICINE; PROTEIN PRECURSORS; TREATMENT OUTCOME;

EID: 84922410230     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.176     Document Type: Editorial

References (9)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
2. Maisel A, Mueller C, Nowak R, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010; 55: 2062-76.
3. Maisel A, Neath SX, Landsberg J, et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail 2012; 14: 278-86.
4. Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 2010; 60: 409-16.
5. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. JAMA 2009; 302: 1059-66.
6. Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitoninguided antibiotic therapy in lower respiratory tract infections in "real life": An international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012; 172: 715-22.
7. Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 2003; 108: 2950-3.
8. Ray P, Birolleau S, Lefort Y, et al. Acute respiratory failure in the elderly: Etiology, emergency diagnosis and prognosis. Crit Care 2006; 10: R82.
9. Giamarellos-Bourboulis EJ, Tsangaris I, Kanni T, et al. Procalcitonin as an early indicator of outcome in sepsis: A prospective observational study. J Hosp Infect 2011; 77: 58-63.